Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information

Websiteimmungene.com
CategoryBioTech
Phone(805) 496-6700
Employees
Founded2007

Offices

Thousand Oaks, USA
558 St. Charles Dr.
Suite 200
Thousand Oaks, CA, 91360
USA

People

Funding

TOTAL $9M
FUNDING TOTAL $9M
Series A, 11/2013
Ally Bridge Group
$9M

Tags

ImmunGene

ImmunGene is a privately held biotechnology company focused on the development of proprietary antibody-cytokine fusion technology and monoclonal antibody-based therapies to treat cancer, autoimmune disorders, and other diseases. ImmunGene has several programs at various stages of development. ImmunGene is funded by federal government grants including the NIH-SBIR and by private investors including several biotechnology executives.

Recent Milestones

Videos

Screenshots

ImmunGene screenshot
Above: ImmunGene Screenshot -- #1
Uploaded: 12/7/13

Sources

  1. ImmunGene Raises $9M in Series A Financing from Ally Bridge Group (finsmes.com) [edit]
Edit This Page
Last Edited 12/7/13

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize ยป

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy